About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Small-fiber Neuropathy in Chronic Kidney Disease | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT01078857

Small-fiber Neuropathy in Chronic Kidney Disease

Neurological dysfunction is a common complication of late stage chronic kidney disease (CKD) and peripheral nerve system is often involved in such complication. Sensory disturbances such as paresthesi...

Lead sponsor: National Taiwan University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Sung-Tsang Hsieh, PhD

CONTACT

886-2-23123456 shsieh@ntu.edu.tw

Sponsors

Lead Sponsor

National Taiwan University Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The patients should fulfill the criteria of CKD according to renal function study and the patients of end-stage renal disease should receive regular dialysis therapy and follow-up at outpatient clinics.
•For disease comparison, patients with peripheral neuropathy of variable etiologies will also be recruited.

Exclusion Criteria

•Poor control DM,
•Severe heart failure,
•Bleeding tendency,
•Severe lung disease with respiratory distress,
•Severe infection,
•Alcoholism,
•Amyloidosis,
•Poor wound healing history.

Related studies

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

RECRUITINGPhase 3

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

NCT05196035 · Chronic Kidney Disease, Proteinuria

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

RECRUITINGPhase 1/2

A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)

NCT06721143 · Chronic Kidney Disease Stage 3

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 2, 2010Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment120

Start dateFeb 2009

Last updatedMar 2, 2010

Condition

Small-Fiber Neuropathy Chronic Kidney Disease

Locations shown

National Taiwan University Hospital

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2010Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions